Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 9 , Pages 994-1009 , September 2008

Effect of Stimulants on Height and Weight: A Review of the Literature

,Accepted 1 April 2008.

References 

  1. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention deficit hyperactivity disorder. J. Clin Psychopharmacol. 2004;54:24–29
  2. Faraone SV. Understanding the effect size of ADHD medications: implications for clinical care. Medscape Psychiatry Ment Health. 2003;8;http://www.medscape.com/viewarticle/461543Accessed May 30, 2008
  3. De Zegher F, Van Den Berghe G, Devlieger H, Eggermont E, Veldhuis JD. Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr Res. 1993;34:642–645
  4. Stata Corporation . Stata User's Guide: Release 9. College Station, TX: Stata Corporation; 2005;
  5. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. 1967;1:221–233
  6. Faraone SV, Biederman J, Monuteaux M, Spencer T. Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/hyperactivity disorder on growth. J. Child Adolesc Psychopharmacol. 2005;15:191–202
  7. Faraone SV, Giefer EE. Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J. Am Acad Child Adolesc Psychiatry. 2007;46:1138–1147
  8. Spencer T, Faraone SV, Biederman J, et al. Does prolonged stimulant therapy suppress growth in children with ADHD? Analysis of data from 21 months of therapy with once-daily OROS® MPH. J. Am Acad Child Adolesc Psychiatry. 2006;45:527–537
  9. Swanson JM, Ruff DD, Feldman PD, Furr AJ, Allen AJ. Characterization of growth in children with ADHD. Paper presented at the American Academy of Child and Adolescent Psychiatry Annual Meeting, October 2005; Toronto.
  10. Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J. Paediatr Child Health. 2003;39:180–185
  11. Klein R, Mannuzza S. Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry. 1988;45:1131–1134
  12. Gittelman R, Landa B, Mattes J, Klein D. Methylphenidate and growth in hyperactive children: a controlled withdrawal study. Arch Gen Psychiatry. 1988;45:1127–1130
  13. Kaffman M, Sher A, Bar-Sinai N. MBD children-variability in developmental patterns or growth inhibitory effect of stimulants?. Isr Ann Psychiatr Relat Discip. 1979;17:58–66
  14. Gross M. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. J Pediatr. 1976;58:423–431
  15. Safer D, Allen R, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr. 1975;86:113–116
  16. Sarterfield JH, Cantwell DP, Schell A, Blaschke T. Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry. 1979;36:212–217
  17. MTA Cooperative Group . National Institute of Mental Health Multi-modal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113:762–769
  18. Lisska MC, Rivkees SA. Daily methylphenidare use slows the growth of children: a community based study. J Pediatr Endocrinol Metab. 2003;16:711–718
  19. Safer D, Allen R. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. J Pediatr. 1973;51:660–667
  20. Greenhill LL, Puig-Antich J, Chambers W, Rubinstein B, Halpern F, Sachar EJ. Growth hormone, prolactin, and growth tesponses in hyperkinetic males treated with D-amphetamine. J. Am Acad Child Psychiatry. 1981;20:84–103
  21. Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of merhylphenidate. Arch Gen Psychiatry. 1983;40:317–321
  22. Zeiner P. Body growth and cardiovascular function after extended treatment (1.75 years) with methylphenidate in boys with attention-deficit hyperactivity disorder. J. Child Adolesc Psychopharmacol. 1995;5:129–138
  23. Quinn PO, Rapoport JL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry. 1975;132:241–245
  24. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. Stimulant treatment over five years: effects on growth. J. Am Acad Child Adolesc Psychiatry. 2006;45:415–421
  25. Pliszka S, Matthews TL, Braslow KJ, Watson MA. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder. J. Am Acad Child Adolesc Psychiatry. 2006;45:520–526
  26. Swanson J, Greenhill L, Wigal T, et al. Stimulant-related reductions of growth rates in the PATS. J. Am Acad Child Adolesc Psychiatry. 2006;45:1304–1313
  27. Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics. 1996;98:763–769
  28. Sund AM, Zeiner P. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?. Nord J Psychiatry. 2002;56:53–57
  29. Zhang HY, Du ML, Zhuang SQ, Liu MN. Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder. Zhonghua Er Ke Za Zhi. 2005;43:723–727
  30. McNutt B, Ballard JE, Boileau R. The effects of long-term stimulant medication on growth and body composition of hyperactive children. Psychopharmacol Bull. 1976;12:13–15
  31. McNutt BA, Boileau RA, Cohen MN. The effects of long-term stimulant medication on the growth and body composition of hyperactive children [proceedings]. Psychopharmacol Bull. 1977;13:36–38
  32. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J. Am Acad Child Adolesc Psychiatry. 2007;46:1015–1027
  33. Hechtman L, Weiss G, Perlman T. Young adult outcome of hyperactive children who received long-term stimulant treatment. J. Am Acad Child Psychiatry. 1984;23:261–269
  34. Kramer JR, Loney J, Ponto LB, Roberts MA, Grossman S. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. J. Am Acad Child Adolesc Psychiatry. 2000;39:517–524
  35. Vincent J, Varley C, Leger P. Effects of methylphenidate on early adolescent growth. Am J Psychiatry. 1990;147:501–502
  36. Pizzi WJ, Rode EC, Barnhart JE. Differential effects of methylphenidate on the growth of neonatal and adolescent rats. Neurol Teratol. 1987;9:107–111
  37. Spencer T, Biederman J, Harding M, O'Donnell D, Faraone S, Wilens T. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?. J. Am Acad Child Adolesc Psychiatry. 1996;35:1460–1469
  38. Biederman J, Faraone SV, Monuteaux M, Plunkett E, Gifford J, Spencer T. Growth deficits and ADHD revisited: impact of gender, development and treatment. Pediatrics. 2003;111:1010–1016
  39. Steinhausen HC, Dorr HG, Kannenberg R, Malin Z. The behavior profile of children and adolescents with short stature. J Dev Behav Pediatr. 2000;21:423–428
  40. Pine DS, Cohen P, Brook J. Emotional problems during youth as predictors of stature during early adulthood: results from a prospective epidemiologic study. Pediatrics. 1996;97:856–863
  41. Kranzler JH, Rosenbloom AL, Proctor B, Diamond FB, Watson M. Is short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr. 2000;136:96–102
  42. Rao JK, Julius JR, Breen TJ, Blethen SL. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy. Pediatrics. 1998;102:497–500
  43. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry. 2003;2:104–113
  44. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics. 1998;102:501–506
  45. Cantwell DP. Hyperactive children have grown up: what have we learned about what happens to them?. Arch Gen Psychiatry. 1985;42:1026–1028
  46. Faraone S, Biederman J, Mick E. The age dependent decline of attention-deficit/hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36:159–165
  47. Lurie S, O'Quinn A. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. J. Neuropsychiatry. 1991;3:41–50
  48. Aarskog D, Fevang F, Klove H, Stoa F, Thorsen T. The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children. Pediatrics. 1977;90:136–139
  49. Hunt RD, Cohen DJ, Anderson G, Clark L. Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity. Life Sci. 1984;35:885–897
  50. Schultz F, Hayford J, Wolraich M, Hintz R, Thompson R. Methylphenidate treatment of hyperactive children: effects on the hypothalamic-pituitary-somatomedin axis. J Pediatr. 1982;70:987–992
  51. Shaywitz SE, Hunt RD, Jatlow P, et al. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate. Pediatrics. 1982;69:688–694
  52. Garfinkel B, Brown W, Klee S, Braden W, Beauchesne R, Shapiro S. Neuroendocrine and cognitive responses to amphetamine in adolescents with a history of attention deficit disorder. J. Am Acad Child Adolesc Psychiatry. 1986;25:503–508
  53. Weizman R, Dick J, Gil AI, Weitz R, Tyano S, Laron Z. Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity. Life Sci. 1987;40:2247–2252
  54. Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IFG-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res. 2005;63:159–164
  55. Greenhill LL, Puig-Antich J, Novacenko MA, Solomon M. Prolactin, growth hormone and growth responses in boys with attention deficit disorder and hyperactivity treated with methylphenidate. J. Am Acad Child Psychiatry. 1984;23:58–67
  56. Toren P, Silbergeld A, Eldar S, et al. Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor 1. Clin Neuropharmacol. 1997;20:264–269
  57. Overtoom CC, Verbaten MN, Kemner C, et al. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav Brain Res. 2003;145:7–15
  58. Sallee FR, Stiller RL, Perel JM. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. J. Am Acad Child Adolesc Psychiatry. 1992;31:244–251
  59. Dickinson LC, Lee J, Ringdahl IC, Schedewie HK, Kilgore BS, Elders MJ. Impaired growth in hyperkinetic children receiving pemoline. Pediatrics. 1979;94:538–541
  60. Kilgore BS, Dickinson MA, Burnett CR, Lee J, Schedewie HK, Elders MJ. Alterations in cartilage metabolism by neurostimulant drugs. J Pediatr. 1979;94:542–545
  61. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav. 2007;87:426–433
  62. Adriani W, Leo D, Guarino M, et al. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Ann N Y Acad Sci. 2006;1074:52–73
  63. Gharib H, Cook DM, Saenger PH, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children—2003 update. Endocr Pract. 2003;9:64–76
  64. Spencer T, Biederman J, Wright V, Danon M. Growth deficits in children treated with desipramine: a controlled study. J. Am Acad Child Adolesc Psychiatry. 1992;31:235–243
  65. Zachor DA, Roberts AW, Bart Hodgens J, Isaacs JS, Merrick J. Effects of long-term psychostimulant medication on growth of children with ADHD. Res Dev Disabil. 2006;27:162–174

 This article was reviewed under and accepted by Ad Hoc Editor Kenneth Towbin, M.D.Article Plus (online-only) materials for this article appear on the Journal's Web site:www.jaacap.com.This article is the subject of an editorial by Dr. Kenneth Towbin in this issue.

PII: S0890-8567(08)60076-3

doi: 10.1097/CHI.ObO13e31817eOea7

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 9 , Pages 994-1009 , September 2008

Article Tools

* Image Usage & Resolution